Regulation of tumour necrosis factor signalling: live or let die

THE UBIQUITIN SYSTEM

Hershko, A., & Ciechanover, A. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.425 · Cited by 8,840

The ubiquitin code

Komander, D., & Rape, M. (2012) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060310-170328 · Cited by 3,679

Smac, a Mitochondrial Protein that Promotes Cytochrome c–Dependent Caspase Activation by Eliminating IAP Inhibition

Du, C., Fang, M., Li, Y., Li, L., & Wang, X. (2000) · Cell · doi:10.1016/s0092-8674(00)00008-8 · Cited by 3,513

Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009

Kroemer, G., Galluzzi, L., Vandenabeele, P., Abrams, J., Alnemri, E. S., Baehrecke, E. H., Blagosklonny, M. V., El-Deiry, W. S., Golstein, P., Green, D. R., et al. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2008.150 · Cited by 3,399

A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells

Black, R. A., Rauch, C. T., Kozlosky, C. J., Peschon, J. J., Slack, J. L., Wolfson, M. F., Castner, B. J., Stocking, K. L., Reddy, P., Srinivasan, S., et al. (1997) · Nature · doi:10.1038/385729a0 · Cited by 3,149

Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury

Degterev, A., Huang, Z., Boyce, M., Li, Y., Jagtap, P., Mizushima, N., Cuny, G. D., Mitchison, T. J., Moskowitz, M. A., & Yuan, J. (2005) · Nature Chemical Biology · doi:10.1038/nchembio711 · Cited by 3,068

FLICE, A Novel FADD-Homologous ICE/CED-3–like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling Complex

Muzio, M., Chinnaiyan, A. M., Kischkel, F. C., O'Rourke, K., Shevchenko, A., Ni, J., Scaffidi, C., Bretz, J. D., Zhang, M., Gentz, R., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81266-0 · Cited by 3,046

Signalling pathways of the TNF superfamily: a double-edged sword

Aggarwal, B. B. (2003) · Nature Reviews Immunology · doi:10.1038/nri1184 · Cited by 2,793

Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes

Micheau, O., & Tschopp, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00521-x · Cited by 2,738

NF-κB at the crossroads of life and death

Karin, M., & Lin, A. (2002) · Nature Immunology · doi:10.1038/ni0302-221 · Cited by 2,709

Mixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 Kinase

Sun, L., Wang, H., Wang, Z., He, S., Chen, S., Liao, D., Wang, L., Yan, J., Liu, W., Lei, X., et al. (2012) · Cell · doi:10.1016/j.cell.2011.11.031 · Cited by 2,698

Suppression of TNF-α-Induced Apoptosis by NF-κB

Antwerp, D. J. V., Martin, S. J., Kafri, T., Green, D. R., & Verma, I. M. (1996) · Science · doi:10.1126/science.274.5288.787 · Cited by 2,581

Inhibition of death receptor signals by cellular FLIP

Irmler, M., Thome, M., Hahne, M., Schneider, P., Hofmann, K., Steiner, V., Bodmer, J.-L., Schröter, M., Burns, K., Mattmann, C., et al. (1997) · Nature · doi:10.1038/40657 · Cited by 2,548

Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and Malignancies

Bongartz, T., Sutton, A. J., Sweeting, M. J., Buchan, I. E., Matteson, E. L., & Montori, V. M. (2006) · JAMA · doi:10.1001/jama.295.19.2275 · Cited by 2,470

Phosphorylation-Driven Assembly of the RIP1-RIP3 Complex Regulates Programmed Necrosis and Virus-Induced Inflammation

Cho, Y., Challa, S., Moquin, D., Genga, R., Ray, T. D., Guildford, M., & Chan, F. K.-M. (2009) · Cell · doi:10.1016/j.cell.2009.05.037 · Cited by 2,435

Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012

Galluzzi, L., Vitale, I., Abrams, J. M., Alnemri, E. S., Baehrecke, E. H., Blagosklonny, M. V., Dawson, T. M., Dawson, V. L., El-Deiry, W. S., Fulda, S., et al. (2012) · Cell Death & Differentiation · doi:10.1038/cdd.2011.96 · Cited by 2,421

Molecular mechanisms of necroptosis: an ordered cellular explosion

Vandenabeele, P., Galluzzi, L., Vanden Berghe, T., & Kroemer, G. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2970 · Cited by 2,382

Purification and Characterization

Tsai, C. S. (2006) · Biomacromolecules · doi:10.1002/0470080124.ch3 · Cited by 2,368

Passive Immunization Against Cachectin/Tumor Necrosis Factor Protects Mice from Lethal Effect of Endotoxin

Beutler, B., Milsark, I. W., & Cerami, A. (1985) · Science · doi:10.1126/science.3895437 · Cited by 2,344

Receptor Interacting Protein Kinase-3 Determines Cellular Necrotic Response to TNF-α

He, S., Wang, L., Miao, L., Wang, T., Du, F., Zhao, L., & Wang, X. (2009) · Cell · doi:10.1016/j.cell.2009.05.021 · Cited by 2,214

TAK1 is a ubiquitin-dependent kinase of MKK and IKK

Wang, C., Deng, L., Hong, M., Akkaraju, G. R., Inoue, J.-I., & Chen, Z. J. (2001) · Nature · doi:10.1038/35085597 · Cited by 2,125

TNF-mediated inflammatory disease

Bradley, Jr. (2008) · The Journal of Pathology · doi:10.1002/path.2287 · Cited by 2,094

The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation

Hsu, H., Xiong, J., & Goeddel, D. V. (1995) · Cell · doi:10.1016/0092-8674(95)90070-5 · Cited by 2,024

TRADD–TRAF2 and TRADD–FADD Interactions Define Two Distinct TNF Receptor 1 Signal Transduction Pathways

Hsu, H., Shu, H., Pan, M., & Goeddel, D. V. (1996) · Cell · doi:10.1016/s0092-8674(00)80984-8 · Cited by 1,998

Fas triggers an alternative, caspase-8–independent cell death pathway using the kinase RIP as effector molecule

Holler, N., Zaru, R., Micheau, O., Thome, M., Attinger, A., Valitutti, S., Bodmer, J.-L., Schneider, P., Seed, B., & Tschopp, J. (2000) · Nature Immunology · doi:10.1038/82732 · Cited by 1,987

RIP3, an Energy Metabolism Regulator That Switches TNF-Induced Cell Death from Apoptosis to Necrosis

Zhang, D.-W., Shao, J., Lin, J., Zhang, N., Lu, B.-J., Lin, S.-C., Dong, M.-Q., & Han, J. (2009) · Science · doi:10.1126/science.1172308 · Cited by 1,931

De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling

Wertz, I. E., O’Rourke, K. M., Zhou, H., Eby, M. T., Aravind, L., Seshagiri, S., Wu, P., Wiesmann, C., Baker, R. T., Boone, D. L., et al. (2004) · Nature · doi:10.1038/nature02794 · Cited by 1,889

Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis.

Keffer, J., Probert, L., Cazlaris, H., Georgopoulos, S., Kaslaris, E., Kioussis, D., & Kollias, G. (1991) · EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04978.x · Cited by 1,675

Treatment of Rheumatoid Arthritis with a Recombinant Human Tumor Necrosis Factor Receptor (p75)–Fc Fusion Protein

Moreland, L. W., Baumgartner, S. W., Schiff, M. H., Tindall, E. A., Fleischmann, R., Weaver, A. L., Ettlinger, R. E., Cohen, S. B., Koopman, W. J., Mohler, K. M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707173370301 · Cited by 1,620

Mixed Lineage Kinase Domain-like Protein MLKL Causes Necrotic Membrane Disruption upon Phosphorylation by RIP3

Wang, H., Sun, L., Su, L., Rizo, J., Liu, L., Wang, L., Wang, F., & Wang, X. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.03.003 · Cited by 1,606

TNF-α Induces Two Distinct Caspase-8 Activation Pathways

Wang, L., Du, F., & Wang, X. (2008) · Cell · doi:10.1016/j.cell.2008.03.036 · Cited by 1,398

Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis

Cai, Z., Jitkaew, S., Zhao, J., Chiang, H.-C., Choksi, S., Liu, J., Ward, Y., Wu, L.-G., & Liu, Z.-G. (2014) · Nature Cell Biology · doi:10.1038/ncb2883 · Cited by 1,322

A novel domain within the 55 kd TNF receptor signals cell death

Tartaglia, L. A., Ayres, T. M., Wong, G. H., & Goeddel, D. V. (1993) · Cell · doi:10.1016/0092-8674(93)90464-2 · Cited by 1,290

Catalytic activity of the caspase-8–FLIPL complex inhibits RIPK3-dependent necrosis

Oberst, A., Dillon, C. P., Weinlich, R., McCormick, L. L., Fitzgerald, P., Pop, C., Hakem, R., Salvesen, G. S., & Green, D. R. (2011) · Nature · doi:10.1038/nature09852 · Cited by 1,278 · cited 3×

The RIP1/RIP3 Necrosome Forms a Functional Amyloid Signaling Complex Required for Programmed Necrosis

Li, J., McQuade, T., Siemer, A. B., Napetschnig, J., Moriwaki, K., Hsiao, Y.-S., Damko, E., Moquin, D., Walz, T., McDermott, A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.019 · Cited by 1,222

The Pseudokinase MLKL Mediates Necroptosis via a Molecular Switch Mechanism

Murphy, J. M., Czabotar, P. E., Hildebrand, J. M., Lucet, I. S., Zhang, J.-G., Alvarez-Diaz, S., Lewis, R., Lalaoui, N., Metcalf, D., Webb, A. I., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.06.018 · Cited by 1,220

IAP Antagonists Induce Autoubiquitination of c-IAPs, NF-κB Activation, and TNFα-Dependent Apoptosis

Varfolomeev, E., Blankenship, J. W., Wayson, S. M., Fedorova, A. V., Kayagaki, N., Garg, P., Zobel, K., Dynek, J. N., Elliott, L. O., Wallweber, H. J. A., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.030 · Cited by 1,218

Monocyte deactivation in septic patients: Restoration by IFN-γ treatment

Döcke, W.-D., Randow, F., Syrbe, U., Krausch, D., Asadullah, K., Reinke, P., Volk, H.-D., & Kox, W. (1997) · Nature Medicine · doi:10.1038/nm0697-678 · Cited by 1,190

The safety and side effects of monoclonal antibodies

Hansel, T. T., Kropshofer, H., Singer, T., Mitchell, J. A., & George, A. J. T. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3003 · Cited by 1,185

TNF-Dependent Recruitment of the Protein Kinase RIP to the TNF Receptor-1 Signaling Complex

Hsu, H., Huang, J., Shu, H.-B., Baichwal, V., & Goeddel, D. V. (1996) · Immunity · doi:10.1016/s1074-7613(00)80252-6 · Cited by 1,182

INHIBITORY EFFECT OF TNF$alpha; ANTIBODIES ON SYNOVIAL CELL INTERLEUKIN-1 PRODUCTION IN RHEUMATOID ARTHRITIS

Brennan, F. M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90430-3 · Cited by 1,141

cIAP1 and cIAP2 Facilitate Cancer Cell Survival by Functioning as E3 Ligases that Promote RIP1 Ubiquitination

Bertrand, M. J. M., Milutinovic, S., Dickson, K. M., Ho, W. C., Boudreault, A., Durkin, J. P., Gillard, J. W., Jaquith, J. B., Morris, S. J., & Barker, P. A. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.05.014 · Cited by 1,134

A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: Ramifications for the complex physiology of TNF

Kriegler, M., Perez, C. F., DeFay, K., Albert, I., & Lu, S.-D. (1988) · Cell · doi:10.1016/0092-8674(88)90486-2 · Cited by 1,090

IAP Antagonists Target cIAP1 to Induce TNFα-Dependent Apoptosis

Vince, J. E., Wong, W. W.-L., Khan, N. R., Feltham, R., Chau, D., Ahmed, A. U., Benetatos, C. A., Chunduru, S. K., Condon, S. M., McKinlay, M. A., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.037 · Cited by 1,076

RIP3 mediates the embryonic lethality of caspase-8-deficient mice

Kaiser, W. J., Upton, J. W., Long, A. B., Livingston-Rosanoff, D., Daley-Bauer, L. P., Hakem, R., Caspary, T., & Mocarski, E. S. (2011) · Nature · doi:10.1038/nature09857 · Cited by 1,057

TRAF2-Mediated Activation of NF-κB by TNF Receptor 2 and CD40

Rothe, M., Sarma, V. J., Dixit, V. M., & Goeddel, D. V. (1995) · Science · doi:10.1126/science.7544915 · Cited by 1,050

Activation of IKK by TNFα Requires Site-Specific Ubiquitination of RIP1 and Polyubiquitin Binding by NEMO

Ea, C.-K., Deng, L., Xia, Z.-P., Pineda, G., & Chen, Z. J. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.026 · Cited by 1,026

Type 1 Diabetes: Etiology, Immunology, and Therapeutic Strategies

Van Belle, T. L., Coppieters, K. T., & Von Herrath, M. G. (2011) · Physiological Reviews · doi:10.1152/physrev.00003.2010 · Cited by 1,022

The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination

Kovalenko, A., Chable-Bessia, C., Cantarella, G., Israël, A., Wallach, D., & Courtois, G. (2003) · Nature · doi:10.1038/nature01802 · Cited by 1,018

lnterleukin-2 programs mouse αβ T lymphocytes for apoptosis

Lenardo, M. J. (1991) · Nature · doi:10.1038/353858a0 · Cited by 1,017

Identification of a Molecular Signaling Network that Regulates a Cellular Necrotic Cell Death Pathway

Hitomi, J., Christofferson, D. E., Ng, A., Yao, J., Degterev, A., Xavier, R. J., & Yuan, J. (2008) · Cell · doi:10.1016/j.cell.2008.10.044 · Cited by 989

Involvement of linear polyubiquitylation of NEMO in NF-κB activation

Tokunaga, F., Sakata, S., Saeki, Y., Satomi, Y., Kirisako, T., Kamei, K., Nakagawa, T., Kato, M., Murata, S., Yamaoka, S., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1821 · Cited by 960

Linear ubiquitination prevents inflammation and regulates immune signalling

Gerlach, B., Cordier, S. M., Schmukle, A. C., Emmerich, C. H., Rieser, E., Haas, T. L., Webb, A. I., Rickard, J. A., Anderton, H., Wong, W. W.-L., et al. (2011) · Nature · doi:10.1038/nature09816 · Cited by 940

Inhibition of Caspases Increases the Sensitivity of L929 Cells to Necrosis Mediated by Tumor Necrosis Factor

Vercammen, D., Beyaert, R., Denecker, G., Goossens, V., Loo, G., Declercq, W., Grooten, J., Fiers, W., & Vandenabeele, P. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.9.1477 · Cited by 925

Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis

Zhao, J., Jitkaew, S., Cai, Z., Choksi, S., Li, Q., Luo, J., & Liu, Z.-G. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1200012109 · Cited by 925

Human tumor necrosis factor. Production, purification, and characterization.

Aggarwal, B. B., Kohr, W. J., Hass, P. E., Moffat, B., Spencer, S. A., Henzel, W. J., Bringman, T. S., Nedwin, G. E., Goeddel, D. V., & Harkins, R. N. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)89560-6 · Cited by 917

TAB2 and TAB3 Activate the NF-κB Pathway through Binding to Polyubiquitin Chains

Kanayama, A., Seth, R. B., Sun, L., Ea, C.-K., Hong, M., Shaito, A. A., Chiu, Y., Deng, L., & Chen, Z. J. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.08.008 · Cited by 911

Circuitry of nuclear factor κB signaling

Hoffmann, A., & Baltimore, D. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00375.x · Cited by 907

cIAPs Block Ripoptosome Formation, a RIP1/Caspase-8 Containing Intracellular Cell Death Complex Differentially Regulated by cFLIP Isoforms

Feoktistova, M., Geserick, P., Kellert, B., Panayotova‐Dimitrova, D., Langlais, C., Hupe, M., Cain, K., MacFarlane, M., Häcker, G. A., & Leverkus, M. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.06.011 · Cited by 878

Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey

Aggarwal, B. B., Gupta, S. C., & Kim, J. H. (2012) · Blood · doi:10.1182/blood-2011-04-325225 · Cited by 877

Structural basis of IAP recognition by Smac/DIABLO

Wu, G., Chai, J., Suber, T. L., Wu, J., Du, C., Wang, X., & Shi, Y. (2000) · Nature · doi:10.1038/35050012 · Cited by 863

The IKK Complex, a Central Regulator of NF- B ActivationPreprint

Israël, A. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000158 · Cited by 853

The Ripoptosome, a Signaling Platform that Assembles in Response to Genotoxic Stress and Loss of IAPs

Tenev, T., Bianchi, K., Darding, M., Broemer, M., Langlais, C., Wållberg, F., Zachariou, A., Lopez, J. S., MacFarlane, M., Cain, K., et al. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.06.006 · Cited by 837

Advances in targeting cyclic nucleotide phosphodiesterases

Maurice, D. H., Ke, H., Ahmad, F., Wang, Y., Chung, J. H., & Manganiello, V. C. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4228 · Cited by 824

NF-κB Signals Induce the Expression of c-FLIP

Micheau, O., Lens, S. M. A., Gaide, O., Alevizopoulos, K., & Tschopp, J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.16.5299-5305.2001 · Cited by 809

Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death

Chen, X., Li, W., Ren, J., Huang, D., He, W., Song, Y., Yang, C., Li, W., Zheng, X., Chen, P., et al. (2013) · Cell Research · doi:10.1038/cr.2013.171 · Cited by 803

A ubiquitin ligase complex assembles linear polyubiquitin chains

Kirisako, T., Kamei, K., Murata, S., Kato, M., Fukumoto, H., Kanie, M., Sano, S., Tokunaga, F., Tanaka, K., & Iwaï, K. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601360 · Cited by 803

Tumor necrosis factor identified in multiple sclerosis brain.

Hofman, F. M., Hinton, D. R., Johnson, K. P., & Merrill, J. E. (1989) · The Journal of Experimental Medicine · doi:10.1084/jem.170.2.607 · Cited by 801

Early Lethality, Functional NF-κB Activation, and Increased Sensitivity to TNF-Induced Cell Death in TRAF2-Deficient Mice

Yeh, W., Shahinian, A., Speiser, D. E., Kraunus, J., Billia, F., Wakeham, A. C., de la Pompa, J. L., Ferrick, D. A., Hum, B., Iscove, N. N., et al. (1997) · Immunity · doi:10.1016/s1074-7613(00)80391-x · Cited by 798

Recruitment of the Linear Ubiquitin Chain Assembly Complex Stabilizes the TNF-R1 Signaling Complex and Is Required for TNF-Mediated Gene Induction

Haas, T. L., Emmerich, C. H., Gerlach, B., Schmukle, A. C., Cordier, S. M., Rieser, E., Feltham, R., Vince, J. E., Warnken, U. H., Wenger, T., et al. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.10.013 · Cited by 797

Origin and function of ubiquitin-like proteins

Hochstrasser, M. (2009) · Nature · doi:10.1038/nature07958 · Cited by 784

The Growth Factor Progranulin Binds to TNF Receptors and Is Therapeutic Against Inflammatory Arthritis in Mice

Tang, W., Lu, Y., Tian, Q.-Y., Zhang, Y., Guo, F.-J., Liu, G.-Y., Syed, N. M., Lai, Y., Lin, E. A., Kong, L., et al. (2011) · Science · doi:10.1126/science.1199214 · Cited by 761

Specific Recognition of Linear Ubiquitin Chains by NEMO Is Important for NF-κB Activation

Rahighi, S., Ikeda, F., Kawasaki, M., Akutsu, M., Suzuki, N., Kato, R., Kensche, T., Uejima, T., Bloor, S., Komander, D., et al. (2009) · Cell · doi:10.1016/j.cell.2009.03.007 · Cited by 761

TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivoPreprint

Shim, J., Xiao, C., Paschal, A. E., Bailey, S. T., Rao, P., Hayden, M. S., Lee, K., Bussey, C., Steckel, M., Tanaka, N., et al. (2005) · Genes & Development · doi:10.1101/gad.1360605 · Cited by 747

SHARPIN forms a linear ubiquitin ligase complex regulating NF-κB activity and apoptosis

Ikeda, F., Deribe, Y. L., Skånland, S. S., Stieglitz, B., Grabbe, C., Franz-Wachtel, M., van Wijk, S. J. L., Goswami, P., Nagy, V., Terzic, J., et al. (2011) · Nature · doi:10.1038/nature09814 · Cited by 745

Autoimmune Diseases Induced by TNF-Targeted Therapies

Ramos‐Casals, M., Brito‐Zerón, P., Muñoz, S., Soria, N., Galiana, D., Bertolaccini, M. L., Cuadrado, M. J., & Khamashta, M. A. (2007) · Medicine · doi:10.1097/md.0b013e3181441a68 · Cited by 731

The E3 Ubiquitin Ligase Itch Couples JNK Activation to TNFα-induced Cell Death by Inducing c-FLIPL Turnover

Chang, L., Kamata, H., Solinas, G., Luo, J.-L., Maeda, S., Venuprasad, K., Liu, Y.-C., & Karin, M. (2006) · Cell · doi:10.1016/j.cell.2006.01.021 · Cited by 706

Small-Molecule Inhibition of TNF-α

He, M. M., Stroustrup, A., Oslob, J. D., Flanagan, W. M., Braisted, A. C., Whitty, A., Cancilla, M. T., Wang, J., Lugovskoy, A. A., Yoburn, J. C., et al. (2005) · Science · doi:10.1126/science.1116304 · Cited by 626

Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-κB activation

Wu, C.-J., Conze, D. B., Li, T., Srinivasula, S. M., & Ashwell, J. D. (2006) · Nature Cell Biology · doi:10.1038/ncb1384 · Cited by 619

SHARPIN is a component of the NF-κB-activating linear ubiquitin chain assembly complex

Tokunaga, F., Nakagawa, T., Nakahara, M., Saeki, Y., Taniguchi, M., Sakata, S.-I., Tanaka, K., Nakano, H., & Iwai, K. (2011) · Nature · doi:10.1038/nature09815 · Cited by 609

Noncanonical NF-κB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK

Zarnegar, B. J., Wang, Y., Mahoney, D. J., Dempsey, P. W., Cheung, H. H., He, J., Shiba, T. L., Yang, X., Yeh, W., Mak, T. W., et al. (2008) · Nature Immunology · doi:10.1038/ni.1676 · Cited by 607

Anti-TNF-α therapies: the next generation

Palladino, M. A., Bahjat, F. R., Theodorakis, E. A., & Moldawer, L. L. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1175 · Cited by 596

The Structure of Tumor Necrosis Factor-α at 2.6 Å Resolution

Eck, M. J., & Sprang, S. R. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)71533-0 · Cited by 590

Autocrine TNFα Signaling Renders Human Cancer Cells Susceptible to Smac-Mimetic-Induced Apoptosis

Petersen, S. L., Wang, L., Yalcin-Chin, A., Li, L., Peyton, M., Minna, J. D., Harran, P. G., & Wang, X. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.08.029 · Cited by 579

Molecular discrimination of structurally equivalent Lys 63‐linked and linear polyubiquitin chains

Komander, D., Reyes‐Turcu, F. E., Licchesi, J. D. F., Odenwälder, P., Wilkinson, K. D., & Barford, D. (2009) · EMBO Reports · doi:10.1038/embor.2009.55 · Cited by 575

Kinase RIP3 Is Dispensable for Normal NF-κBs, Signaling by the B-Cell and T-Cell Receptors, Tumor Necrosis Factor Receptor 1, and Toll-Like Receptors 2 and 4

Newton, K., Sun, X., & Dixit, V. M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.4.1464-1469.2004 · Cited by 554

RIP mediates tumor necrosis factor receptor 1 activation of NF‐kappaB but not Fas/APO‐1‐initiated apoptosis.

Ting, A. T., Pimentel‐Muiños, F. X., & Seed, B. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01007.x · Cited by 550

Both cIAP1 and cIAP2 regulate TNFα-mediated NF-κB activation

Mahoney, D. J., Cheung, H. H., Mrad, R. L., Plenchette, S., Simard, C., Enwere, E., Arora, V., Mak, T. W., Lacasse, E. C., Waring, J., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711122105 · Cited by 540

The structure of tumor necrosis factor-alpha at 2.6 A resolution. Implications for receptor binding.

Eck, M. J., & Sprang, S. R. (1989) · PubMed · doi:10.2210/pdb1tnf/pdb · Cited by 507

Structure of tumour necrosis factor

Jones, E. Y., Stuart, D. I., & Walker, N. P. C. (1989) · Nature · doi:10.1038/338225a0 · Cited by 503

Death receptor signaling

Lavrik, I. N., Golks, A., & Krammer, P. H. (2005) · Journal of Cell Science · doi:10.1242/jcs.01610 · Cited by 494

Recruitment of TNF Receptor 1 to Lipid Rafts Is Essential for TNFα-Mediated NF-κB Activation

Legler, D. F., Micheau, O., Doucey, M., Tschopp, J., & Bron, C. (2003) · Immunity · doi:10.1016/s1074-7613(03)00092-x · Cited by 473

Clinical targeting of the TNF and TNFR superfamilies

Croft, M., Benedict, C. A., & Ware, C. F. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3930 · Cited by 465

Mlkl knockout mice demonstrate the indispensable role of Mlkl in necroptosis

Wu, J., Huang, Z., Ren, J., Zhang, Z., He, P., Li, Y., Ma, J., Chen, W., Zhang, Y., Zhou, X., et al. (2013) · Cell Research · doi:10.1038/cr.2013.91 · Cited by 462

Cleavage of RIP3 inactivates its caspase-independent apoptosis pathway by removal of kinase domain

Feng, S., Yang, Y., Mei, Y., Ma, L., Zhu, D.-E., Höti, N., Castanares, M. A., & Wu, M. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.05.016 · Cited by 459

Immunogenicity of anti-TNF biologic therapies for rheumatoid arthritis

van Schouwenburg, P. A., Rispens, T., & Wolbink, G. (2013) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2013.4 · Cited by 450

TNF receptor 2 pathway: drug target for autoimmune diseases

Faustman, D., & Davis, M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3030 · Cited by 446

Activation of the canonical IKK complex by K63/M1-linked hybrid ubiquitin chains

Emmerich, C. H., Ordureau, A., Strickson, S., Arthur, J. S. C., Pedrioli, P. G. A., Komander, D., & Cohen, P. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1314715110 · Cited by 442

Selected Treatment Strategies for Septic Shock Based on Proposed Mechanisms of Pathogenesis

Natanson, C., Hoffman, W. D., Suffredini, A. F., Eichacker, P. Q., & Danner, R. L. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-9-199405010-00009 · Cited by 440

The Distinct Roles of TRAF2 and RIP in IKK Activation by TNF-R1

Devin, A., Cook, A., Lin, Y., Rodriguez, Y., Kelliher, M. A., & Liu, Z.-G. (2000) · Immunity · doi:10.1016/s1074-7613(00)80194-6 · Cited by 433

Functional complementation between FADD and RIP1 in embryos and lymphocytes

Zhang, H., Zhou, X., McQuade, T. J., Li, J., Chan, F. K.-M., & Zhang, J. (2011) · Nature · doi:10.1038/nature09878 · Cited by 428

Tumor Necrosis Factor Signaling Requires iRhom2 to Promote Trafficking and Activation of TACE

Adrain, C., Zettl, M., Christova, Y., Taylor, N. A., & Freeman, M. (2012) · Science · doi:10.1126/science.1214400 · Cited by 415

Mitochondrial cell death effectors

Brenner, D., & Mak, T. W. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.09.004 · Cited by 414

How Cytokine Networks Fuel Inflammation: Toward a cytokine-based disease taxonomy

Schett, G., Elewaut, D., McInnes, I. B., Dayer, J.-M., & Neurath, M. F. (2013) · Nature Medicine · doi:10.1038/nm.3260 · Cited by 406

Casper Is a FADD- and Caspase-Related Inducer of Apoptosis

Shu, H., Halpin, D. R., & Goeddel, D. V. (1997) · Immunity · doi:10.1016/s1074-7613(00)80450-1 · Cited by 399

TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis

Gregory, A., Dendrou, C. A., Attfield, K. E., Haghikia, A., Xifara, D. K., Butter, F., Poschmann, G., Kaur, G., Lambert, L., Leach, O. A., et al. (2012) · Nature · doi:10.1038/nature11307 · Cited by 395

Listeria monocytogenes infection as a complication of treatment with tumor necrosis factor α–neutralizing agents

Slifman, N. R., Gershon, S. K., Lee, J., Edwards, E. T., & Braun, M. M. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10758 · Cited by 385

The RIP kinases: crucial integrators of cellular stress

Meylan, E., & Tschopp, J. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2005.01.003 · Cited by 383

Cutting Edge: RIP1 Kinase Activity Is Dispensable for Normal Development but Is a Key Regulator of Inflammation in SHARPIN-Deficient Mice

Berger, S. B., Kasparcova, V., Hoffman, S., Swift, B., Dare, L., Schaeffer, M., Capriotti, C., Cook, M., Finger, J., Hughes-Earle, A., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400499 · Cited by 374

c‐IAP1 and UbcH5 promote K11‐linked polyubiquitination of RIP1 in TNF signalling

Dynek, J. N., Goncharov, T., Dueber, E. C., Fedorova, A. V., Izrael-Tomasevic, A., Phu, L., Helgason, E., Fairbrother, W. J., Deshayes, K., Kirkpatrick, D. S., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.300 · Cited by 369

Survival Function of the FADD-CASPASE-8-cFLIPL Complex

Dillon, C. P., Oberst, A., Weinlich, R., Janke, L. J., Kang, T.-B., Ben-Moshe, T., Mak, T. W., Wallach, D., & Green, D. R. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.03.010 · Cited by 331 · cited 2×

iRhom2 Regulation of TACE Controls TNF-Mediated Protection Against Listeria and Responses to LPS

McIlwain, D. R., Lang, P. A., Maretzky, T., Hamada, K., Ohishi, K., Maney, S. K., Berger, T., Murthy, A., Duncan, G. S., Xu, H. C., et al. (2012) · Science · doi:10.1126/science.1214448 · Cited by 327

Cell death attenuation by `Usurpin', a mammalian DED-caspase homologue that precludes caspase-8 recruitment and activation by the CD-95 (Fas, APO-1) receptor complex

Rasper, D., Vaillancourt, J. P., Hadano, S., Houtzager, V. M., Seiden, I. M., Keen, S., Tawa, P., Xanthoudakis, S., Nasir, J., Martindale, D. W., et al. (1998) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400370 · Cited by 322

New targets for mucosal healing and therapy in inflammatory bowel diseases

Neurath, M. F. (2013) · Mucosal Immunology · doi:10.1038/mi.2013.73 · Cited by 316

Emerging cell and cytokine targets in rheumatoid arthritis

Burmester, G. R., Feist, E., & Dörner, T. (2013) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2013.168 · Cited by 308

RIP1 suppresses innate immune necrotic as well as apoptotic cell death during mammalian parturition

Kaiser, W. J., Daley-Bauer, L. P., Thapa, R. J., Mandal, P., Berger, S. B., Huang, C., Sundararajan, A., Guo, H., Roback, L., Speck, S. H., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1401857111 · Cited by 291 · cited 1×

Anti-tumor necrosis factor therapy in sepsis: Update on clinical trials and lessons learned

Reinhart, K., & Karzai, W. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107001-00037 · Cited by 289

Apoptotic crosstalk of TNF receptors: TNF-R2-induces depletion of TRAF2 and IAP proteins and accelerates TNF-R1-dependent activation of caspase-8

Fotin‐Mleczek, M., Henkler, F., Samel, D., Reichwein, M., Haußer, A., Parmryd, I., Scheurich, P., Schmid, J. A., & Wajant, H. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.13.2757 · Cited by 284

Regulated Commitment of TNF Receptor Signaling

Pimentel‐Muiños, F. X., & Seed, B. (1999) · Immunity · doi:10.1016/s1074-7613(00)80152-1 · Cited by 282

c-FLIPR, a New Regulator of Death Receptor-induced Apoptosis

Golks, A., Brenner, D., Fritsch, C., Krammer, P. H., & Lavrik, I. N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414425200 · Cited by 281

Etanercept Treatment in Children With New-Onset Type 1 Diabetes

Mastrandrea, L. D., Yu, J., Behrens, T., Buchlis, J. G., Albini, C. H., Fourtner, S. H., & Quattrin, T. (2009) · Diabetes Care · doi:10.2337/dc09-0054 · Cited by 280

Function of TRADD in tumor necrosis factor receptor 1 signaling and in TRIF-dependent inflammatory responses

Ermolaeva, M., Michallet, M., Papadopoulou, N., Utermöhlen, O., Kranidioti, K., Kollias, G. A., Tschopp, J., & Pasparakis, M. (2008) · Nature Immunology · doi:10.1038/ni.1638 · Cited by 277

Ubiquitination of RIP Is Required for Tumor Necrosis Factor α-induced NF-κB Activation

Li, H., Kobayashi, M., Blonska, M., You, Y., & Lin, X. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600620200 · Cited by 277

Diverse Sequence Determinants Control Human and Mouse Receptor Interacting Protein 3 (RIP3) and Mixed Lineage Kinase domain-Like (MLKL) Interaction in Necroptotic Signaling

Chen, W., Zhou, Z., Li, L., Zhong, C., Zheng, X., Wu, X., Zhang, Y., Ma, H., Huang, D., Li, W., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.435545 · Cited by 272

TNFR1-dependent cell death drives inflammation in Sharpin-deficient mice

Rickard, J. A., Anderton, H., Etemadi, N., Nachbur, U., Darding, M., Peltzer, N., Lalaoui, N., Lawlor, K. E., Vanyai, H. K., Hall, C. M., et al. (2014) · eLife · doi:10.7554/elife.03464 · Cited by 270

Structural Basis for Recognition of Diubiquitins by NEMO

Lo, Y.-C., Lin, S., Rospigliosi, C. C., Conze, D. B., Wu, C.-J., Ashwell, J. D., Eliezer, D., & Wu, H. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.01.012 · Cited by 257

HOIP Deficiency Causes Embryonic Lethality by Aberrant TNFR1-Mediated Endothelial Cell Death

Peltzer, N., Rieser, E., Taraborrelli, L., Draber, P., Darding, M., Pernaute, B., Shimizu, Y., Sarr, A., Draberova, H., Montinaro, A., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.08.066 · Cited by 257

The Kinase Activity of Rip1 Is Not Required for Tumor Necrosis Factor-α-induced IκB Kinase or p38 MAP Kinase Activation or for the Ubiquitination of Rip1 by Traf2

Lee, T. H.-Y., Shank, J., Cusson, N., & Kelliher, M. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404206200 · Cited by 255

A Ubiquitin Replacement Strategy in Human Cells Reveals Distinct Mechanisms of IKK Activation by TNFα and IL-1β

Xu, M., Skaug, B. A., Zeng, W., & Chen, Z. J. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.10.002 · Cited by 248

Strategies to improve drug development for sepsis

Fink, M. P., & Warren, H. S. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4368 · Cited by 246

Clinical use of anti-TNF therapy and increased risk of infections

Ali, T., Bronze, Kaitha, Mahmood, Ftaisi, & Stone (2013) · Drug Healthcare and Patient Safety · doi:10.2147/dhps.s28801 · Cited by 244

TNFα blockade in human diseases: An overview of efficacy and safety

Lin, J., Ziring, D., Desai, S. B., Kim, S., Wong, M., Korin, Y. D., Braun, J. G., Reed, E. F., Gjertson, D. W., & Singh, R. R. (2007) · Clinical Immunology · doi:10.1016/j.clim.2007.08.012 · Cited by 243

TRAF2 Must Bind to Cellular Inhibitors of Apoptosis for Tumor Necrosis Factor (TNF) to Efficiently Activate NF-κB and to Prevent TNF-induced Apoptosis

Vince, J. E., Pantaki-Eimany, D., Feltham, R., Mace, P. D., Cordier, S. M., Schmukle, A. C., Davidson, A. J., Callus, B. A., Wong, W. W.-L., Gentle, I. E., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.072256 · Cited by 241

TNF-induced necroptosis in L929 cells is tightly regulated by multiple TNFR1 complex I and II members

Vanlangenakker, N., Bertrand, M. J. M., Bogaert, P., Vandenabeele, P., & Berghe, T. V. (2011) · Cell Death and Disease · doi:10.1038/cddis.2011.111 · Cited by 236

TNF superfamily in inflammatory disease: translating basic insights

Croft, M., Duan, W., Choi, H., Eun, S.-Y., Madireddi, S., & Mehta, A. K. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.10.004 · Cited by 232

FLIPL induces caspase 8 activity in the absence of interdomain caspase 8 cleavage and alters substrate specificity

Pop, C., Oberst, A., Drąg, M., van Raam, B. J., Riedl, S. J., Green, D. R., & Salvesen, G. S. (2011) · Biochemical Journal · doi:10.1042/bj20101738 · Cited by 227

NF-κB Suppression by the Deubiquitinating Enzyme Cezanne

Enesa, K., Zakkar, M., Chaudhury, H., Luong, L. A., Rawlinson, L. M., Mason, J. C., Haskard, D. O., Dean, J. L. E., & Evans, P. C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708690200 · Cited by 216

The function of TRADD in signaling through tumor necrosis factor receptor 1 and TRIF-dependent Toll-like receptors

Pobezinskaya, E. L., Kim, Y., Choksi, S., Morgan, M. J., Li, T., Liu, C., & Liu, Z.-G. (2008) · Nature Immunology · doi:10.1038/ni.1639 · Cited by 216

Smac/DIABLO Selectively Reduces the Levels of c-IAP1 and c-IAP2 but Not That of XIAP and Livin in HeLa Cells

Yang, Q.-H., & Du, C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401253200 · Cited by 213

Spontaneous mutations in the mouse Sharpin gene result in multiorgan inflammation, immune system dysregulation and dermatitis

Seymour, R. E., Hasham, M. G., Cox, G. A., Shultz, L. D., HogenEsch, H., Roopenian, D. C., & Sundberg, J. P. (2007) · Genes and Immunity · doi:10.1038/sj.gene.6364403 · Cited by 212

A20 inhibits LUBAC‐mediated NF‐κB activation by binding linear polyubiquitin chains via its zinc finger 7

Verhelst, K., Carpentier, I., Kreike, M., Meloni, L., Verstrepen, L., Kensche, T., Đikić, I., & Beyaert, R. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.240 · Cited by 210

Regulation of TNF‐α with a focus on rheumatoid arthritis

Moelants, E. A. V., Mortier, A., Damme, J. V., & Proost, P. (2013) · Immunology and Cell Biology · doi:10.1038/icb.2013.15 · Cited by 207

Crystal Structures of the TRAF2: cIAP2 and the TRAF1: TRAF2: cIAP2 Complexes: Affinity, Specificity, and Regulation

Zheng, C., Kabaleeswaran, V., Wang, Y., Cheng, G., & Wu, H. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.03.009 · Cited by 206

Receptor-interacting protein (RIP) kinase family

Zhang, D., Lin, J., & Han, J. (2010) · Cellular and Molecular Immunology · doi:10.1038/cmi.2010.10 · Cited by 203

Structural Insights into RIP3-Mediated Necroptotic Signaling

Xie, T., Peng, W., Yan, C., Wu, J., Gong, X., & Shi, Y. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.08.044 · Cited by 196

Drug Insight: tumor necrosis factor-converting enzyme as a pharmaceutical target for rheumatoid arthritis

Moss, M. L., Sklair‐Tavron, L., & Nudelman, R. (2008) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0797 · Cited by 195

Paradoxical inflammation induced by anti-TNF agents in patients with IBD

Cleynen, I., & Vermeire, S. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.125 · Cited by 192

A Novel Mechanism of TRAF Signaling Revealed by Structural and Functional Analyses of the TRADD–TRAF2 Interaction

Park, Y. C., Ye, H., Hsia, C. Y., Segal, D., Rich, R. L., Liou, H.-C., Myszka, D. G., & Wu, H. (2000) · Cell · doi:10.1016/s0092-8674(00)80889-2 · Cited by 188

Challenges and approaches for the development of safer immunomodulatory biologics

Sathish, J. G., Sethu, S., Bielsky, M.-C., de Haan, L., French, N. S., Govindappa, K., Green, J., Griffiths, C. E. M., Holgate, S. T., Jones, D., et al. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3974 · Cited by 186

Tumor necrosis factor induces GSK3 kinase–mediated cross-tolerance to endotoxin in macrophages

Park, S. H., Park‐Min, K., Chen, J., Hu, X., & Ivashkiv, L. B. (2011) · Nature Immunology · doi:10.1038/ni.2043 · Cited by 183

Efficacy and safety of the fully human anti-tumour necrosis factor α monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study

van de Putte, L. B. A., Rau, R., Breedveld, F. C., Kalden, J. R., Malaise, M. G., van Riel, P. L. C. M., Schattenkirchner, M., Emery, P., Burmester, G. R., Zeidler, H., et al. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.009563 · Cited by 176

iRHOM2 is a critical pathogenic mediator of inflammatory arthritis

Issuree, P. D. A., Maretzky, T., McIlwain, D. R., Monette, S., Qing, X., Lang, P. A., Swendeman, S. L., Park‐Min, K., Binder, N. B., Kalliolias, G. D., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66168 · Cited by 162

Anti-TNF-α therapy for patients with sepsis: a systematic meta-analysis

Lv, S., Han, M. A. T., Yi, R., Kwon, S., Dai, C., & Wang, R. (2014) · International Journal of Clinical Practice · doi:10.1111/ijcp.12382 · Cited by 158

Competitive Control of Independent Programs of Tumor Necrosis Factor Receptor-Induced Cell Death by TRADD and RIP1

Zheng, L., Bidère, N., Staudt, D., Cubre, A., Orenstein, J. M., Chan, F. K.-M., & Lenardo, M. J. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.9.3505-3513.2006 · Cited by 155

Novel therapeutic strategies for multiple sclerosis — a multifaceted adversary

Lopez-Diego, R. S., & Weiner, H. L. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2358 · Cited by 154

Anti-TNF therapy

Thalayasingam, N., & Isaacs, J. D. (2011) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2011.10.004 · Cited by 138

Monoclonal antibody therapy-associated neurological disorders

the BIOGEAS Study Group, Bosch, X., Saiz, A., & Ramos‐Casals, M. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.1 · Cited by 137

Selective death of autoreactive T cells in human diabetes by TNF or TNF receptor 2 agonism

Ban, L., Zhang, J. Y., Wang, L., Kühtreiber, W. M., Burger, D., & Faustman, D. L. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803429105 · Cited by 130

Phosphodiesterase 4-targeted treatments for autoimmune diseases

Kumar, N., Goldminz, A. M., Kim, N., & Gottlieb, A. B. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-96 · Cited by 122

Infectious and Malignant Complications of TNF Inhibitor Therapy in IBD

Targownik, L. E., & Bernstein, C. N. (2013) · The American Journal of Gastroenterology · doi:10.1038/ajg.2013.294 · Cited by 118

Structural Basis for the Lack of E2 Interaction in the RING Domain of TRAF2

Yin, Q., Lamothe, B., Darnay, B. G., & Wu, H. (2009) · Biochemistry · doi:10.1021/bi901462e · Cited by 117

Beyond tumor necrosis factor receptor: TRADD signaling in toll-like receptors

Chen, N., Chio, I. I. C., Lin, W., Duncan, G. S., Chau, H., Katz, D., Huang, H.-L., Pike, K. A., Hao, Z., Su, Y.-W., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806585105 · Cited by 116

Cellular FLICE-inhibitory Protein (cFLIP) Isoforms Block CD95- and TRAIL Death Receptor-induced Gene Induction Irrespective of Processing of Caspase-8 or cFLIP in the Death-inducing Signaling Complex

Kavuri, S. M., Geserick, P., Berg, D., Dimitrova, D. P., Feoktistova, M., Siegmund, D., Gollnick, H., Neumann, M., Wajant, H., & Leverkus, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.148585 · Cited by 92

CARP-2 Is an Endosome-Associated Ubiquitin Ligase for RIP and Regulates TNF-Induced NF-κB Activation

Liao, W., Xiao, Q., Tchikov, V., Fujita, K.-I., Yang, W., Wincovitch, S., Garfield, S. H., Conze, D. B., El‐Deiry, W. S., Schütze, S., et al. (2008) · Current Biology · doi:10.1016/j.cub.2008.04.017 · Cited by 83

Genetics of Psoriasis and Pharmacogenetics of Biological Drugs

Prieto‐Pérez, R., Cabaleiro, T., Daudén, E., Ochoa, D., Román, M. C., & Abad‐Santos, F. (2013) · Autoimmune Diseases · doi:10.1155/2013/613086 · Cited by 78

Induction of the NF-κB Cascade by Recruitment of the Scaffold Molecule NEMO to the T Cell Receptor

Weil, R., Schwamborn, K., Alcover, A., Chable-Bessia, C., Bartolo, V. D., & Israël, A. (2003) · Immunity · doi:10.1016/s1074-7613(02)00506-x · Cited by 71

New drugs beyond biologics in rheumatoid arthritis: the kinase inhibitors

Bonilla-Hernán, M.-G., Miranda‐Carús, M., & Martín-Mola, E. (2011) · Lara D. Veeken · doi:10.1093/rheumatology/ker192 · Cited by 60

Development of type 1 diabetes in a patient treated with anti-TNF-α therapy for active rheumatoid arthritis

Tack, C. J., Kleijwegt, F. S., van Riel, P. L. C. M., & Roep, B. O. (2009) · Diabetologia · doi:10.1007/s00125-009-1381-0 · Cited by 54

Future prospects in biologic therapy for systemic lupus erythematosus

Stohl, W. (2013) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2013.136 · Cited by 54

Developments in therapies for spondyloarthritis

Sieper, J. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2012.40 · Cited by 51

Procaspase 8 overexpression in non-small-cell lung cancer promotes apoptosis induced by FLIP silencing

Wilson, T. R., Redmond, K. M., McLaughlin, K. M., Crawford, N., Gately, K. A., O'Byrne, K. J., Le-Clorrenec, C., Holohan, C., Fennell, D. A., Johnston, P. G., et al. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.76 · Cited by 48

Tumor Necrosis Factor Receptor 2 (TNFR2) Signaling Is Negatively Regulated by a Novel, Carboxyl-terminal TNFR-associated Factor 2 (TRAF2)-binding Site

Grech, A. P., Gardam, S., Chan, T. D., Quinn, R., Gonzales, R., Basten, A., & Brink, R. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504849200 · Cited by 47

Antagonistic TNF Receptor One-Specific Antibody (ATROSAB): Receptor Binding and In Vitro Bioactivity

Richter, F., Liebig, T., Guenzi, E., Herrmann, A., Scheurich, P., Pfizenmaier, K., & Kontermann, R. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072156 · Cited by 40

Certolizumab pegol in the treatment of rheumatoid arthritis: a comprehensive review of its clinical efficacy and safety

Mease, P. J. (2010) · Lara D. Veeken · doi:10.1093/rheumatology/keq285 · Cited by 40

Anti-TNF rescue CD4+Foxp3+ regulatory T cells in patients with type 1 diabetes from effects mediated by TNF

Ryba-Stanisławowska, M. E., Marek-Trzonkowska, N. M., Hak, Ł., Rybarczyk-Kapturska, K., Myśliwiec, M., Trzonkowski, P., & Myśliwska, J. M. (2011) · Cytokine · doi:10.1016/j.cyto.2011.05.006 · Cited by 37

Short-term Risk of Total Malignancy and Nonmelanoma Skin Cancers with Certolizumab and Golimumab in Patients with Rheumatoid Arthritis: Metaanalysis of Randomized Controlled Trials

Blay, P. L., Mouterde, G., Barnetche, T., Morel, J., & Combe, B. G. (2012) · The Journal of Rheumatology · doi:10.3899/jrheum.110982 · Cited by 35

Presence of a population of CD20+,CD38? B lymphocytes with defective proliferative responsiveness in the synovial compartment of patients with rheumatoid arthritis

Reparon‐Schuijt, C. C., van Esch, W. J. E., van Kooten, C., Ezendam, N. P. M., Levarht, E. W. N., Breedveld, F. C., & Verweij, C. L. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200109)44:9 · Cited by 34

Infliximab Inhibits Activation and Effector Functions of Peripheral Blood T Cells in vitro from Patients with Clinically Active Ulcerative Colitis

Dahlén, R., Strid, H., Lundgren, A., Isaksson, S., Raghavan, S., Magnusson, M. K., Simrén, M., Sjövall, H., & Öhman, L. (2013) · Scandinavian Journal of Immunology · doi:10.1111/sji.12081 · Cited by 32

TNF-Alpha Antagonism in Severe Asthma?

Desai, D., & Brightling, C. E. (2010) · Recent Patents on Inflammation & Allergy Drug Discovery · doi:10.2174/187221310793564218 · Cited by 31

Drug Insight: anti-tumor necrosis factor therapies for the vasculitic diseases

Langford, C. A. (2008) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0825 · Cited by 21

Untitled work

Shigeyama (2000) · doi:10.1002/1529-0131(200011)43:11

Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018.

Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680

Immunotherapy in colorectal cancer: Rationale, challenges and potential

Ganesh, K., Stadler, Z. K., Cercek, A., Mendelsohn, R. B., Shia, J., Segal, N. H., & Diaz, L. A. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0126-x · Cited by 1,954

The Role of Tumor Necrosis Factor Alpha (TNF-α) in Autoimmune Disease and Current TNF-α Inhibitors in Therapeutics

Jang, D.-I., Lee, A.-H., Shin, H.-Y., Song, H.-R., Park, J.-H., Kang, T., Lee, S., & Yang, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052719 · Cited by 1,864

TNF biology, pathogenic mechanisms and emerging therapeutic strategies

Kalliolias, G. D., & Ivashkiv, L. B. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.169 · Cited by 1,453

Reactive Oxygen Species: Drivers of Physiological and Pathological Processes

Checa, J., & Aran, J. M. (2020) · Journal of Inflammation Research · doi:10.2147/jir.s275595 · Cited by 1,068

Targeting sTNF/TNFR1 Signaling as a New Therapeutic Strategy

Fischer, R., Kontermann, R. E., & Maier, O. (2015) · Antibodies · doi:10.3390/antib4010048 · Cited by 90

Death by TNF: a road to inflammation

Loo, G., & Bertrand, M. J. M. (2022) · Nature reviews. Immunology · doi:10.1038/s41577-022-00792-3 · Cited by 1,035

Tumor Necrosis Factor Signaling Pathways

Rajput, A., & Ware, C. F. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-394447-4.30048-7 · Cited by 12

The Balance of TNF Mediated Pathways Regulates Inflammatory Cell Death Signaling in Healthy and Diseased Tissues

Webster, J. D., & Vucic, D. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00365 · Cited by 324

Tumour necrosis factor (TNF) receptor family (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

MacEwan, D. J. (2019) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f334/2019.4 · Cited by 1